暂无分享,去创建一个
Friedrich Rippmann | Sepp Hochreiter | Günter Klambauer | Thomas Unterthiner | Kristina Preuer | S. Hochreiter | Thomas Unterthiner | G. Klambauer | F. Rippmann | Kristina Preuer
[1] Thomas Unterthiner,et al. Multi-Task Deep Networks for Drug Target Prediction , 2015 .
[2] Jie Li,et al. Evaluation of Different Methods for Identification of Structural Alerts Using Chemical Ames Mutagenicity Data Set as a Benchmark. , 2017, Chemical research in toxicology.
[3] Timon Schroeter,et al. Visual Interpretation of Kernel‐Based Prediction Models , 2011, Molecular informatics.
[4] Alán Aspuru-Guzik,et al. Convolutional Networks on Graphs for Learning Molecular Fingerprints , 2015, NIPS.
[5] Osman F. Güner,et al. Pharmacophore perception, development, and use in drug design , 2000 .
[6] Sepp Hochreiter,et al. Coulomb GANs: Provably Optimal Nash Equilibria via Potential Fields , 2017, ICLR.
[7] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[8] J. Kazius,et al. Derivation and validation of toxicophores for mutagenicity prediction. , 2005, Journal of medicinal chemistry.
[9] Günter Klambauer,et al. DeepTox: Toxicity Prediction using Deep Learning , 2016, Front. Environ. Sci..
[10] Andreas Bender,et al. DeepSynergy: predicting anti-cancer drug synergy with Deep Learning , 2017, Bioinform..
[11] Klaus-Robert Müller,et al. Benchmark Data Set for in Silico Prediction of Ames Mutagenicity , 2009, J. Chem. Inf. Model..
[12] Sepp Hochreiter,et al. Self-Normalizing Neural Networks , 2017, NIPS.
[13] Antonio Lavecchia,et al. Machine-learning approaches in drug discovery: methods and applications. , 2015, Drug discovery today.
[14] Bolei Zhou,et al. Network Dissection: Quantifying Interpretability of Deep Visual Representations , 2017, 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[15] Thomas Blaschke,et al. Molecular de-novo design through deep reinforcement learning , 2017, Journal of Cheminformatics.
[16] Andreas Mayr,et al. Deep Learning as an Opportunity in Virtual Screening , 2015 .
[17] Koji Tsuda,et al. ChemTS: an efficient python library for de novo molecular generation , 2017, Science and technology of advanced materials.
[18] E. Lionta,et al. Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances , 2014, Current topics in medicinal chemistry.
[19] Ankur Taly,et al. Axiomatic Attribution for Deep Networks , 2017, ICML.
[20] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[21] P. Willett,et al. PHARMACOPHORE PERCEPTION , DEVELOPMENT , AND USE IN DRUG DESIGN , 2011 .
[22] Shu-Kun Lin. Pharmacophore Perception, Development and Use in Drug Design. Edited by Osman F. Güner , 2000 .
[23] David M. Reif,et al. Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway , 2014, Scientific Reports.
[24] Alexandre Tkatchenko,et al. Quantum-chemical insights from deep tensor neural networks , 2016, Nature Communications.
[25] Thierry Kogej,et al. Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks , 2017, ACS central science.
[26] Alja Plošnik,et al. Mutagenic and carcinogenic structural alerts and their mechanisms of action , 2016, Arhiv za higijenu rada i toksikologiju.
[27] Markus H. Gross,et al. Gradient-Based Attribution Methods , 2019, Explainable AI.
[28] Igor V. Tetko,et al. ToxAlerts: A Web Server of Structural Alerts for Toxic Chemicals and Compounds with Potential Adverse Reactions , 2012, J. Chem. Inf. Model..
[29] Motoaki Kawanabe,et al. How to Explain Individual Classification Decisions , 2009, J. Mach. Learn. Res..
[30] Hugo Ceulemans,et al. Large-scale comparison of machine learning methods for drug target prediction on ChEMBL† †Electronic supplementary information (ESI) available: Overview, Data Collection and Clustering, Methods, Results, Appendix. See DOI: 10.1039/c8sc00148k , 2018, Chemical science.
[31] Vijay S. Pande,et al. Molecular graph convolutions: moving beyond fingerprints , 2016, Journal of Computer-Aided Molecular Design.
[32] Sepp Hochreiter,et al. Fréchet ChemNet Distance: A Metric for Generative Models for Molecules in Drug Discovery , 2018, J. Chem. Inf. Model..
[33] Cengiz Öztireli,et al. Towards better understanding of gradient-based attribution methods for Deep Neural Networks , 2017, ICLR.
[34] Yoshua Bengio,et al. Deep Learning of Representations: Looking Forward , 2013, SLSP.
[35] J. Dearden,et al. QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.
[36] Robert P. Sheridan,et al. Deep Neural Nets as a Method for Quantitative Structure-Activity Relationships , 2015, J. Chem. Inf. Model..
[37] Samuel S. Schoenholz,et al. Neural Message Passing for Quantum Chemistry , 2017, ICML.